These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11587629)
1. Designing an AIDS vaccine. Laurence J AIDS Patient Care STDS; 2001 Sep; 15(9):449-51. PubMed ID: 11587629 [No Abstract] [Full Text] [Related]
2. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development. Heeney JL; Hahn BH AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855 [No Abstract] [Full Text] [Related]
3. Seeking new pathways for HIV vaccine discovery. Flores J Future Microbiol; 2009 Feb; 4(1):1-7. PubMed ID: 19207094 [No Abstract] [Full Text] [Related]
4. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Hanke T; McMichael AJ Nat Med; 2000 Sep; 6(9):951-5. PubMed ID: 10973301 [No Abstract] [Full Text] [Related]
5. Controversial HIV vaccine enters phase III trials amid skepticism. AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059 [TBL] [Abstract][Full Text] [Related]
6. PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey. Fauci AS; Marston HD Science; 2015 Jul; 349(6246):386-7. PubMed ID: 26206922 [No Abstract] [Full Text] [Related]
7. Current strategies and limitations of HIV vaccines. Kawalekar OU; Shedlock DJ; Weiner DB Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169 [TBL] [Abstract][Full Text] [Related]
8. Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS. Voss G; Villinger F AIDS; 2000; 14 Suppl 3():S153-65. PubMed ID: 11086858 [No Abstract] [Full Text] [Related]
9. Biological considerations in the development of a human immunodeficiency virus vaccine. Nathanson N; Mathieson BJ J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092 [TBL] [Abstract][Full Text] [Related]
10. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes. Yang OO AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558 [No Abstract] [Full Text] [Related]
11. Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative. Tucker TJ; Mazithulela G BMJ; 2004 Aug; 329(7463):454-6. PubMed ID: 15321907 [TBL] [Abstract][Full Text] [Related]
12. Future directions in HIV vaccine development. Koff WC; Glass MJ AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1313-5. PubMed ID: 1466948 [No Abstract] [Full Text] [Related]
13. Antibodies to HIV-1: aiming at the right target. Eggink D; Melchers M; Sanders RW Trends Microbiol; 2007 Jul; 15(7):291-4. PubMed ID: 17566740 [TBL] [Abstract][Full Text] [Related]
14. Grappling with global concerns in the search for an HIV vaccine. Grady C J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666 [TBL] [Abstract][Full Text] [Related]
15. G-8 endorses new global HIV vaccine enterprise. Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292 [No Abstract] [Full Text] [Related]
17. What if we had an AIDS vaccine? Lancet; 2000 Jul; 356(9224):85. PubMed ID: 10963237 [No Abstract] [Full Text] [Related]
18. Is the Salk principle still viable for the design of an effective HIV vaccine? Lundgren JD HIV Med; 2004 Sep; 5(5):315-6. PubMed ID: 15369505 [No Abstract] [Full Text] [Related]
19. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise. Council of the Global HIV Vaccine Enterprise Nat Med; 2010 Sep; 16(9):981-9. PubMed ID: 20823883 [No Abstract] [Full Text] [Related]
20. No vaccine against HIV yet--are we not perfectly equipped? Singh M Virol J; 2006 Aug; 3():60. PubMed ID: 16939652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]